Optimizer Smart System
Jump to navigation
Jump to search
Indications
- heart failure not amenable to cardiac resynchronization therapy
Procedure
- includes a pulse generator implanted under the skin of the chest connected to 3 leads implanted in the heart
- device delivers impulses to the heart to modulate strength of cardiac contraction rather than cardiac rhythm
More general terms
References
- ↑ Young K, Sofair A, Chavey WE New Heart Failure Device Approved Physician's First Watch, March 22, 2019 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
FDA News Release. March 21, 2019 FDA approves new device for treating moderate to severe chronic heart failure in patients https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm634103.htmhttps://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm634103.htm